亚洲日韩欧美综合-亚洲日韩欧美一区二区在线-亚洲日韩欧美视频-亚洲日韩精品欧美一区二区-国产欧美日韩综合

會員登錄|免費注冊|忘記密碼|管理入口 返回主站||保存桌面|手機瀏覽|聯系方式|購物車
企業會員第1年

湖北拓楚慷元醫藥有限公司  

精細化工,化工中間體

搜索
新聞中心
  • 暫無新聞
產品分類
  • 暫無分類
聯系方式
  • 聯系人:陳琳
  • 電話:027-86939098
  • 傳真:027-86939098
  • QQ:1990527136
站內搜索
 
榮譽資質
  • 暫未上傳
友情鏈接
  • 暫無鏈接
首頁 > 供應產品 > 苯乙雙胍生產苯乙雙胍,苯乙雙胍廠家
苯乙雙胍生產苯乙雙胍,苯乙雙胍廠家
單價 22.00 / 公斤對比
銷量 暫無
發貨 湖北武漢市付款后24小時內
庫存 900公斤起訂1公斤
品牌 拓楚
型號 114-86-3
規格 原料藥
過期 長期有效
更新 2013-05-23 22:29
 
詳細信息

苯乙雙胍

   苯乙雙胍生產苯乙雙胍苯乙雙胍廠家,好的苯乙雙胍,武漢苯乙雙胍,湖北苯乙雙胍苯乙雙胍

苯乙雙胍產品類別: 醫藥原料和中間體 苯乙雙胍苯乙雙胍苯乙雙胍苯乙雙胍

苯乙雙胍苯乙雙胍產品含量: 99% 苯乙雙胍苯乙雙胍苯乙雙胍苯乙雙胍苯乙雙胍

苯乙雙胍化學式: C10H15N5 苯乙雙胍苯乙雙胍苯乙雙胍苯乙雙胍苯乙雙胍

苯乙雙胍CAS編號: 114-86-3 苯乙雙胍苯乙雙胍苯乙雙胍苯乙雙胍苯乙雙胍

苯乙雙胍質量標準: BP/CP 苯乙雙胍苯乙雙胍苯乙雙胍苯乙雙胍苯乙雙胍

苯乙雙胍包裝規格: 25公斤/桶 苯乙雙胍苯乙雙胍苯乙雙胍苯乙雙胍苯乙雙胍

苯乙雙胍產品說明: 常用其。白色結晶性粉末。易溶于水。在乙醇中溶解,在氯仿或苯乙雙胍幾乎不溶

苯乙雙胍能降低肝糖分解和促進肌糖合成,從而降低血糖。用于治療非胰島素依賴型糖苯乙雙胍尿病及部分胰島素依賴型糖尿病

我公司主要生產以下優質產品:醋酸氯已定,噻康唑,丁香醛,酮洛芬,來氟米特,吡羅昔康,氨甲環酸,卡托普利,格列美脲,乙亞胺,阿霉素

©2025 湖北拓楚慷元醫藥有限公司 版權所有   技術支持:化工網   訪問量:7663  
 
主站蜘蛛池模板: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |